High 'on treatment' platelet reactivity in the Intensive Care Unit

Trial Profile

High 'on treatment' platelet reactivity in the Intensive Care Unit

Phase of Trial: Phase III

Latest Information Update: 01 Aug 2017

At a glance

  • Drugs Aspirin (Primary) ; Aspirin (Primary) ; Clopidogrel (Primary) ; Prasugrel (Primary) ; Ticagrelor (Primary)
  • Indications Acute coronary syndromes; Angina pectoris; Arterial occlusive disorders; Arterial thrombosis; Atherosclerosis; Myocardial infarction; Stroke; Thrombosis
  • Focus Pharmacodynamics
  • Acronyms HTPR-ICU
  • Most Recent Events

    • 01 Aug 2017 Results of patients treated with prasugrel 10 mg (n=23) published in the Thrombosis and Haemostasis.
    • 19 Apr 2017 Planned number of patients changed from 216 to 248.
    • 22 Mar 2017 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top